Singapore vs Tajikistan: Immunization, Hib3
Singapore
97.0%
in 2024
Tajikistan
97.0%
in 2024
Singapore rank
29th
Tajikistan rank
29th
Immunization, Hib3 over time
- Singapore
- Tajikistan
How they compare
Singapore currently reports 97.0% against 97.0% in Tajikistan, a difference of 0.0%.
The two have swapped places 6 times across 12 shared years of data; in 2013 it was Tajikistan ahead.
Singapore ranks 29th and Tajikistan ranks 29th of 191 countries.
Across the 2 decades both report, Singapore averaged higher in 1 and Tajikistan in 1.
Head to head by decade
| Decade | Singapore | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 93.1% | 96.6% | 3.4% | Tajikistan |
| 2020s | 97.6% | 96.8% | 0.8% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Singapore or Tajikistan?
- Singapore, at 97.0% against 97.0% in Tajikistan as of 2024.
- What is the difference in immunization, hib3 between Singapore and Tajikistan?
- 0.0%, with Singapore ahead.
- How many years of comparable data are there for Singapore and Tajikistan?
- 12 years are reported by both, from 2013 to 2024.
- How do Singapore and Tajikistan rank globally for immunization, hib3?
- Singapore ranks 29th and Tajikistan ranks 29th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.